Jianlan Liu

Nanjing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Correction: Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq.

Correction: Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq.

Journal: Frontiers in immunology
Published: March 10, 2026

Mitochondrial metabolism restoration via Tramiprosate suppresses mitochondrial ROS-driven foamy macrophage senescence post spinal cord injury.

Mitochondrial metabolism restoration via Tramiprosate suppresses mitochondrial ROS-driven foamy macrophage senescence post spinal cord injury.

Journal: Journal of orthopaedic translation
Published: September 08, 2025

Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma.

Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma.

Journal: Journal for immunotherapy of cancer
Published: July 11, 2025

USP5-Mediated PD-L1 deubiquitination regulates immunotherapy efficacy in melanoma.

USP5-Mediated PD-L1 deubiquitination regulates immunotherapy efficacy in melanoma.

Journal: Journal of translational medicine
Published: March 29, 2025

Research on the preparation of antimicrobial material based on thermoplastic polyurethane and drug release control.

Research on the preparation of antimicrobial material based on thermoplastic polyurethane and drug release control.

Journal: Drug delivery and translational research
Published: November 20, 2024

Unveiling ac4C modification pattern: a prospective target for improving the response to immunotherapeutic strategies in melanoma.

Unveiling ac4C modification pattern: a prospective target for improving the response to immunotherapeutic strategies in melanoma.

Journal: Journal of translational medicine
Published: October 30, 2024

Prognostic and Immunotherapeutic Value of Regulatory T Cell Marker Gene Signature in Melanoma.

Prognostic and Immunotherapeutic Value of Regulatory T Cell Marker Gene Signature in Melanoma.

Journal: Iranian journal of allergy, asthma, and immunology
Published: October 28, 2024

Necroptosis-related LncRNAs in skin cutaneous melanoma: evaluating prognosis, predicting immunity, and guiding therapy.

Necroptosis-related LncRNAs in skin cutaneous melanoma: evaluating prognosis, predicting immunity, and guiding therapy.

Journal: BMC cancer
Published: March 30, 2023

Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq.

Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq.

Journal: Frontiers in immunology
Published: March 19, 2023

Integrating single-cell analysis and machine learning to create glycosylation-based gene signature for prognostic prediction of uveal melanoma.

Integrating single-cell analysis and machine learning to create glycosylation-based gene signature for prognostic prediction of uveal melanoma.

Journal: Frontiers in endocrinology
Published: February 10, 2023

Liquid-liquid phase separation throws novel insights into treatment strategies for skin cutaneous melanoma.

Liquid-liquid phase separation throws novel insights into treatment strategies for skin cutaneous melanoma.

Journal: BMC cancer
Published: January 27, 2023

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma.

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma.

Journal: Frontiers in oncology
Published: November 03, 2022
Showing 1-12 of 13

Last Updated: 09/26/2026